<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE ArticleSet PUBLIC "-//NLM//DTD PubMed 2.0//EN" "http://www.ncbi.nlm.nih.gov:80/entrez/query/static/PubMed.dtd">
<ArticleSet><Article><Journal><PublisherName></PublisherName><JournalTitle>Knowledge &amp; Health Journal</JournalTitle><Issn>1735-577X</Issn><Volume>4</Volume><Issue>3</Issue><PubDate PubStatus="epublish"><Year>2009</Year><Month>12</Month><Day>29</Day></PubDate></Journal><VernacularTitle>Estimating Relative Survival of Breast Cancer Patients Referring to Imam Khomeini Cancer Institute during 1990-95</VernacularTitle><FirstPage>1</FirstPage><LastPage>7</LastPage><ELocationID EIdType="doi">10.1234/knh.v4i3.178</ELocationID><Language>FA</Language><AuthorList><Author><FirstName>Amir</FirstName><LastName>Kasaeian</LastName><Affiliation>دانشگاه علوم پزشکی شاهرود- گروه علوم پايه- مربی. amir_kasaeian@yahoo.com</Affiliation></Author><Author><FirstName>Alireza</FirstName><LastName>Abadi</LastName></Author><Author><FirstName>Yadollah</FirstName><LastName>Mehrabi</LastName></Author><Author><FirstName>Alireza</FirstName><LastName>Mousavi Jarrahi</LastName></Author></AuthorList><History><PubDate PubStatus="received"><Year>2013</Year><Month>08</Month><Day>20</Day></PubDate></History><Abstract>Introduction: In comparison with observed and cause-specific survival, relative survival, as an estimate of net survival, has become a more preferred measure for the analysis of patients’ survival based on data from population-based-cancer registries. This research is carried out to estimate and investigate the net survival of breast cancer patients.Methods: In order to estimate relative survival, we used Finnish annual probabilities of death as a standard source to estimate expected survival in this study. Data consist of 662 breast cancer patients diagnosed at the cancer institute of Imam Khomeini hospital during 1990-95 and followed up to the end of 2000. Data were analyzed using SAS software, version 9.1.Results: The results showed that the three-year relative survival for 3 age groups of 15-44, 45-59 and 60-74 were 85, 90 and 80% respectively, whereas it was low for the age group of 75+ (67%). Following up the age group of 45-59 for two consequent years, the estimate of relative survival ratio was obtained approximately one. For some intervals, the follow-up estimate of relative survival was greater than one.Conclusion: Based on the results, survival following diagnosis of cancer has decreased with the increasing of age groups. It is also seen that, with the increasing years of follow-up, survival following diagnosis of cancer has first decreased and then a little increased. The decreasing rate for age group of 75+ is noticeable. The statistical cure point for the age group of 45-59 is acceptable but for the age groups of 45-59 and 60-74, the quality of following up is low in some follow-up intervals. </Abstract></Article></ArticleSet>
